Article
Tumor Microenvironment Properties are Associated With Low CD68-positive Cell Infiltration and Favorable Disease-free Survival in EGFR-mutant Lung Adenocarcinoma.
Clinical lung cancer - 1 Sept 2018
Gong Zhihua, Chen Junying, Cheng Jia-Nan, Sun Chengdu, Jia Qingzhu, Diao Xinwei, Zhu Bo
Abstract excerpt
BACKGROUND: The benefits of immune checkpoint inhibitors for first-line treatment in patients with lung adenocarcinoma harboring EGFR mutations are unclear. The effects of ICIs depend on the tumor microenvironment (TME). Differences in TME properties between mutant and wild-type EGFR have not been fully characterized. PATIENTS AND METHODS: We collected 105 surgically resected (50 EGFR mutated and 55 EGFR...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
